B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

IYD

MOLECULAR TARGET

iodotyrosine deiodinase

UniProt: Q6PHW0NCBI Gene: 3894341 compounds

IYD (iodotyrosine deiodinase) is targeted by 1 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting IYD

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Monoiodotyrosine0.691

About IYD as a Drug Target

IYD (iodotyrosine deiodinase) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 1 compounds with documented IYD interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

IYD inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.